tetrachloroisophthalonitrile has been researched along with Esophageal Reflux in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morley-Fletcher, A; Rodriguez, L; Timothy, B; Winter, H | 1 |
| Briel, D; Reimer, J; Schaper, O; Schulz, M | 1 |
| Amundson, JR; Che, S; Hedberg, HM; Ishii, S; Joseph, S; Kuchta, K; Ujiki, MB; VanDruff, VN; Zimmermann, CJ; Zukancic, H | 1 |
| Shaw, S | 1 |
4 other study(ies) available for tetrachloroisophthalonitrile and Esophageal Reflux
| Article | Year |
|---|---|
Evaluation of Gastroesophageal Reflux Disease in Children on the Autism Spectrum: A Study Evaluating the Tolerance and Utility of the BRAVO Wireless pH Monitoring.
Topics: Autism Spectrum Disorder; Autistic Disorder; Child; Esophageal pH Monitoring; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Nitriles; Retrospective Studies | 2022 |
[Home Treatment "Bremen ambulant vor Ort (BravO)"].
Topics: Esophageal pH Monitoring; Gastroesophageal Reflux; Germany; Humans | 2022 |
Acid exposure time better predicts outcomes following anti-reflux surgery than DeMeester score.
Topics: Esophagitis; Gastroesophageal Reflux; Humans; Prospective Studies; Quality of Life; Retrospective Studies; Treatment Outcome | 2023 |
Bravo!
Topics: Female; Gastroesophageal Reflux; Humans; Nitriles; Physicians, Family | 2019 |